5 Years of FDA Approvals in Lymphoma: Who They've Helped and What Comes Next

Five years ago, if standard chemotherapy and immunotherapy had stopped working for your lymphoma, CAR-T cell therapy was still brand new and available at only a handful of specialized centers. Today, an entirely different category of drug — the bispecific antibody — didn't exist for lymphoma at all in 2021, and now covers multiple lymphoma types with several FDA-approved drugs to pick from. Here's a look at exactly what the FDA has approved, year by year, and what it's actually meant for patients along the way, told partly through CURE's own reporting.